NetworkNewsBreaks

FridayJun 07, 2019 1:28 pm

NetworkNewsBreaks – Sugarmade Inc. (SGMD) Gains Traction in Industrial Hemp Sector

Sugarmade (OTCQB: SGMD), a major supplier to the growing hydroponic cultivation sector, entered into a supply contract with Hempistry Inc. in April, securing its spot in the newly legal industrial hemp sector  (http://nnw.fm/81Jfc). A recent article discussing Sugarmade reads, “‘With at least 42,000 acres of hemp expected to be planted in Kentucky and considering an average plant density per acre of well over 1,000, farmers in Kentucky will need hundreds of millions of clones over the coming years,’ Sugarmade CEO Jimmy Chan, who is also a Hempistry director, stated in the news release. ‘When these numbers are multiplied over the many…

Continue Reading

FridayJun 07, 2019 1:17 pm

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Expands Cultivation Operations Following Health Canada Authorization

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently received Health Canada approval to start cultivation work in a 20,000-square-foot Ontario facility (http://nnw.fm/77tPH). An article discussing the company reads, “The Ontario facility, which is part of a complex containing three buildings that will have a combined annual production capacity of 17,500 kilograms of cannabis once they are completed later this summer, will begin planting in the near future. The Green Organic Dutchman expects to produce about 200,000 kilograms (about 440,000 pounds) of cannabis every year when all of its operations reach full capacity, growing…

Continue Reading

FridayJun 07, 2019 11:57 am

NetworkNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Enters Strategic Partnership with PAX Labs

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) this morning announced its entry into an agreement with Pax Labs, Inc. Under the agreement, Supreme Cannabis will become a foundational brand partner and supplier for the PAX Era in Canada, pending federal legalization of the vaporizable products. "Supreme Cannabis is excited to be partnering with PAX to provide consumers with the ultimate vaporizing experience. Together, we expect to deliver 7ACRES' multi-award winning flower extracted into oils exclusively for use in North America's best-selling premium vaporizer, the PAX Era," Supreme Cannabis CEO Navdeep Dhaliwal stated in the news release. "7ACRES has…

Continue Reading

FridayJun 07, 2019 11:12 am

NetworkNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Selected as a Canadian Launch Partner of PAX Era

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), a leading licensed producer of cannabis and extract-based products, today announced that it was selected as one of the four Canadian launch partners of PAX Era, the premium oil vaporizer created by PAX Labs, Inc. PAX Labs is a leading consumer technology brand in the design and development of premium vaporizers for dry flower, as well as concentrates when they become legal in Canada later this year. “Cannabis 2.0 – the next generation of legal, adult use cannabis products – represents a world of opportunity,” Organigram CEO Greg Engel said in the news release.…

Continue Reading

FridayJun 07, 2019 11:02 am

NetworkNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Closes $10M Brokered Private Placement

TransCanna Holdings (CSE: TCAN) (FSE: TH8) today announced the close of its brokered private placement of 2,000,350 units which were sold at a price of CAD$5.00 each, resulting in total gross proceeds of CAD$10,001,750. Each unit sold comprised of one common share and one half of one common share purchase warrant. Warrant holders are entitled to acquire an additional share at a price of $6.00 for each full warrant until June 7, 2022. TransCanna paid a commission of 7% of the total gross proceeds through a payment of $700,122.50 in cash as well as a corporate finance fee of $150,000,…

Continue Reading

FridayJun 07, 2019 9:59 am

NetworkNewsBreaks – NetworkNewsWire to Join FWD Pharma to Foster Richly Rewarding Experience for August 2019 Conference

Multifaceted financial news and publishing company NetworkNewsWire (“NNW”) will serve as the Official Newswire and Media Sponsor for the FWD Pharma Conference. The event will be held at the Doubletree by Hilton Hotel Philadelphia City Center in historic Philadelphia, Pennsylvania from August 6 through August 8, 2019. “FWD Pharma has an impressive strategy of joining industry professionals with interactive panels, case studies and hands-on workshops to help attendees truly understand the importance of today’s digital journey,” NNW Communications Director Jonathan Keim said in the news release. “In any data-driven environment, it’s essential to stay up to date on the next-level…

Continue Reading

FridayJun 07, 2019 9:46 am

NetworkNewsBreaks – Pacific Software Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal

Emerging business development technology innovator Pacific Software (OTC: PFSF) on Thursday announced its entry into a Memorandum of Understanding (“MOU”) with Sao Paulo, Brazil-based Império Assessoria em Informaçoes LTDA. Under the agreement, the parties agree to commercially market and promote the activities of the commodities trade portal BOAPIN.com powered by Pacific Software and Atlas Cargo Suite, an agribusiness, logistics management software module owned and operated by Império. “This collaboration will include the commercial marketing and promotion of the BOAPIN.com platform as a front-end e-commerce solution and the assimilation of ‘Chain Integration Intelligence,’ a client application from the Atlas Cargo Suite…

Continue Reading

ThursdayJun 06, 2019 3:08 pm

NetworkNewsBreaks – VPR Brands LP (VPRB) Reports Increased Revenues, Reduced Net Loss

Innovative technology holding company VPR Brands LP (OTC: VPRB) released the results of fiscal operations for first quarter 2019. Among other highlights, the company reported continually increasing revenues and a narrowing net loss. An article discussing the company reads, “VPRB’s revenues grew about 31% year over year to $1.3 million for the quarter, according to the report (http://nnw.fm/Jp09m), continuing the trend reported for the full year in 2018, when revenues grew nearly 28% to $4.6 million (http://nnw.fm/deMB3), and indicating that the company has begun 2019 at a strong pace that could eclipse the prior year if it continues. . . . VPR…

Continue Reading

ThursdayJun 06, 2019 2:50 pm

NetworkNewsBreaks – QMC Quantum Minerals Corp. (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ) Confirms Significant Spodumene Mineralization on Irgon Property

QMC Quantum Minerals (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ), a British Columbia-based company engaged in the business of acquisition, exploration and development of natural resource properties, is actively advancing its Irgon Lithium Mine. A recent article discussing the company reads, “During the recent Irgon drill program, the company announced that Cabot Corp., the owners of the nearby Tantalum Mining Corporation of Canada’s (TANCO) mine, had provided QMC with the opportunity to evaluate and re-sample the drill core that TANCO retained in storage from its 1978 drill program. This historical drilling was undertaken on the Central and Mapetre pegmatite dikes, which…

Continue Reading

ThursdayJun 06, 2019 2:41 pm

NetworkNewsBreaks – Why Endonovo Therapeutics Inc. (ENDV) Is ‘One to Watch’

Endonovo Therapeutics (OTCQB: ENDV) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. A recent article discussing the company reads, “Endonovo Therapeutics develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, noninvasive medical devices are designed to deliver the company’s proprietary, patent protected electroceutical therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (‘CNS’) disorders.” To view the full article, visit http://nnw.fm/T7FSm About Endonovo Therapeutics Inc. Endonovo Therapeutics is a commercial-stage developer of noninvasive…

Continue Reading